Adiponectin Resistance in Heart Failure and the Emerging Pattern of Metabolic Failure in Chronic Heart Failure
- 1 March 2010
- journal article
- research article
- Published by Ovid Technologies (Wolters Kluwer Health) in Circulation: Heart Failure
- Vol. 3 (2), 181-182
- https://doi.org/10.1161/circheartfailure.110.945063
Abstract
No abstract availableKeywords
This publication has 12 references indexed in Scilit:
- Functional Adiponectin Resistance at the Level of the Skeletal Muscle in Mild to Moderate Chronic Heart FailureCirculation: Heart Failure, 2010
- Adiponectin is increased in cardiac cachexia irrespective of body mass indexEuropean Journal of Heart Failure, 2009
- Resistin, Adiponectin, and Risk of Heart FailureJournal of the American College of Cardiology, 2008
- Cardiac cachexia: A systematic overviewPharmacology & Therapeutics, 2008
- New insights into mechanisms of statin-associated myotoxicityCurrent Opinion in Pharmacology, 2008
- Serum Concentrations of Adiponectin and Risk of Type 2 Diabetes Mellitus and Coronary Heart Disease in Apparently Healthy Middle-Aged Men: Results From the 18-Year Follow-Up of a Large Cohort From Southern GermanyJournal of the American College of Cardiology, 2006
- Plasma Adiponectin, Body Mass Index, and Mortality in Patients With Chronic Heart FailureCirculation, 2005
- Impaired Insulin Sensitivity as an Independent Risk Factor for Mortality in Patients With Stable Chronic Heart FailureJournal of the American College of Cardiology, 2005
- Growth hormone resistance in chronic heart failure and its therapeutic implicationsJournal of Cardiac Failure, 2003
- The “Muscle Hypothesis” of Chronic Heart FailureJournal of Molecular and Cellular Cardiology, 1996